SL-164
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
CAS Number | 3476-88-8 |
PubChem (CID) | 63386 |
ChemSpider | 57049 |
Chemical and physical data | |
Formula | C16H12Cl2N2O |
Molar mass | 319.185 |
3D model (Jmol) | Interactive image |
| |
|
SL-164 is an analogue of methaqualone developed in the late 1960s by a team at Sumitomo.[1] SL-164 has similar sedative, hypnotic and anticonvulsant properties to the parent compound, but was never marketed for clinical use.[2]
References
- ↑ US Patent 3651230 COMPOSITIONS AND METHODS FOR TRANQUILIZING WITH SUBSTITUTED 3-PHENYL-4-QUINAZOLINONE DERIVATIVES
- ↑ Saito, C.; Sakai, S.; Yukawa, Y.; Yamamoto, H.; Takagi, H. (1969). "Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4H)-quinazolinone (SL-164)". Arzneimittel-Forschung. 19 (12): 1945–1949. PMID 4985336.
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids | |
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: GABAergics |
This article is issued from Wikipedia - version of the 9/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.